What does my Lymphoma pathology report mean
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Your Lymphoma Pathology Report
I'd be happy to help you understand your pathology report! However, I don't see that you've uploaded or shared your actual report yet.
To give you the most helpful explanation, please:
- Upload or paste your pathology report, or
- Share the key findings from it (like the lymphoma type, biomarkers, or test results)
What I Can Help You Understand
Once you share your report, I can explain:
✅ The lymphoma type - What kind of lymphoma you have (like follicular lymphoma, marginal zone lymphoma, DLBCL, etc.)
✅ Biomarkers and immunophenotype - What markers like CD20+, CD10+, BCL2+, or others mean and why doctors test for them
✅ Genetic mutations - Any specific mutations found (like BCL6, TP53, etc.) and what they generally indicate
✅ Stage and grade - What these mean for your diagnosis
✅ What findings typically suggest - How doctors use these results to guide treatment decisions
✅ Questions to ask your team - Specific questions that will help you understand YOUR particular situation better
Important Note
According to the NCCN Guidelines for Patients: Marginal Zone Lymphomas, pathology reports contain important information about mutations and genetic changes in your lymphoma cells. As the guidelines explain, "MZL cells sometimes have changes in genes and chromosomes that can be seen under a microscope or found with other tests. These DNA changes may affect your MZL diagnosis, treatment options, and prognosis."
Please share your report, and I'll walk you through what it means in plain language.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphoma (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Lymphoma patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: